ArticleACS omega2026

Structure-Based Drug Discovery of Triazine Derivatives as Potent and Orally Bioavailable AXL Inhibitors for Cancer Therapy.

Mingming Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.